These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1347443)
1. Surrogate markers in AIDS: where are we? Where are we going? Lagakos SW; Hoth DF Ann Intern Med; 1992 Apr; 116(7):599-601. PubMed ID: 1347443 [No Abstract] [Full Text] [Related]
2. HIV surrogate markers weighed. Cotton P JAMA; 1991 Mar; 265(11):1357, 1361-2. PubMed ID: 1671883 [No Abstract] [Full Text] [Related]
3. CD4 counts as surrogate markers for progression to AIDS. Harris PJ Ann Intern Med; 1994 Jan; 120(1):88. PubMed ID: 7902690 [No Abstract] [Full Text] [Related]
4. CD4 counts as surrogate markers for progression to AIDS. Phillips AN; Sabin CA Ann Intern Med; 1994 Jan; 120(1):87-8. PubMed ID: 7902689 [No Abstract] [Full Text] [Related]
5. CD4 counts as surrogate markers for progression to AIDS. Hirschel B Ann Intern Med; 1994 Jan; 120(1):87; author reply 88. PubMed ID: 7902687 [No Abstract] [Full Text] [Related]
6. Surrogate markers in AIDS and cancer trials. Fleming TR Stat Med; 1994 Jul 15-30; 13(13-14):1423-35; discussion 1437-40. PubMed ID: 7973222 [TBL] [Abstract][Full Text] [Related]
10. Surrogate markers in AIDS clinical trials: conceptual basis, validation, and uncertainties. Lagakos SW Clin Infect Dis; 1993 Feb; 16 Suppl 1():S22-5. PubMed ID: 8093844 [TBL] [Abstract][Full Text] [Related]
11. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)]. Töglhofer W Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278 [No Abstract] [Full Text] [Related]
12. [Pentoxifylline in the treatment of AIDS]. Ruiz-Argüelles GJ; Lobato-Mendizábal E; Ruiz-Argüelles A; Lagunes-Yannelli B Rev Invest Clin; 1992; 44(2):285-6. PubMed ID: 1359620 [No Abstract] [Full Text] [Related]
13. Surrogate markers of disease studied as means of determining AIDS drugs' effectiveness. Cotton P JAMA; 1990 Nov; 264(18):2362, 2365. PubMed ID: 1977933 [No Abstract] [Full Text] [Related]
14. Surrogate markers in AIDS. Nuako K Ann Intern Med; 1992 Oct; 117(7):619. PubMed ID: 1355955 [No Abstract] [Full Text] [Related]
16. Chemokine (C-C motif) receptor 5 entry inhibitors: new class of drugs for acquired immune deficiency syndrome. Jacovina A; New M Mt Sinai J Med; 2008; 75(3):297-8. PubMed ID: 18704982 [No Abstract] [Full Text] [Related]
17. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Choi S; Lagakos SW; Schooley RT; Volberding PA Ann Intern Med; 1993 May; 118(9):674-80. PubMed ID: 8096373 [TBL] [Abstract][Full Text] [Related]
18. Surrogate end points in clinical trials. Ellenberg SS BMJ; 1991 Jan; 302(6768):63-4. PubMed ID: 1671650 [No Abstract] [Full Text] [Related]
19. Searching for markers on the AIDS trail. Cohen J Science; 1992 Oct; 258(5081):388-90. PubMed ID: 1357750 [No Abstract] [Full Text] [Related]
20. CD4 counts as surrogate markers for progression to AIDS. Nightingale SD Ann Intern Med; 1994 Jan; 120(1):87; author reply 88. PubMed ID: 7902688 [No Abstract] [Full Text] [Related] [Next] [New Search]